- Clinical Trials
- April 2025
- 40 Pages
Global
From €1144EUR$1,250USD£972GBP
- Report
- June 2024
- 200 Pages
Global
From €7277EUR$7,950USD£6,185GBP
- Report
- May 2024
- 129 Pages
Global
From €5949EUR$6,499USD£5,056GBP
- Drug Pipelines
- November 2020
- 40 Pages
Global
From €1831EUR$2,000USD£1,556GBP
Gingivitis is a common form of gum disease caused by the buildup of plaque on the teeth. It is characterized by red, swollen, and bleeding gums. Gingivitis is typically treated with a combination of professional dental cleaning and good oral hygiene. Pharmaceuticals play an important role in the treatment of gingivitis, with a variety of drugs available to help reduce inflammation and prevent further damage to the gums.
Common gingivitis drugs include antibiotics, antiseptics, and anti-inflammatory medications. Antibiotics are used to reduce the number of bacteria in the mouth, while antiseptics help to reduce inflammation and prevent further infection. Anti-inflammatory medications help to reduce swelling and pain associated with gingivitis.
Some of the companies in the gingivitis drug market include GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies produce a variety of drugs to treat gingivitis, including antibiotics, antiseptics, and anti-inflammatory medications. Show Less Read more